Thermo Fisher Scientific (TMO) valuation, revenue & earnings

P/E and P/S history, revenue and growth, ROIC vs. cost of capital, segments, earnings and analyst forecasts

At a glance

Market capitalisation$250B

Moat ratingNarrow moat

ValuationExpensive

Revenue, and where it comes from$44.6bn in 2025: Lab Products and Biopharma Services $24.0bn, Life Sciences Solutions $10.4bn, Analytical Instruments $7.6bn, Specialty Diagnostics $4.7bn, less $2.0bn between segments

Recent years are exact, taken from company filings; the earliest years are approximate. Forecast figures are Wall Street consensus, not company guidance. Read the full Thermo Fisher Scientific moat analysis →